Wnt secretion blocking is also very effective in inhibiting CRC growth using patient-derived xenograft models with RSPO3 fusion proteins that potentially engage RNF43/ZNRF3 to increase membrane FZD levels and sensitize Wnt response (44). Here, RNF43 is linked to colorectal carcinoma.